From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

Our latest news roundup reports on Amgen’s $900 million investment, EMA’s re-examination of donanemab, philanthropy at Sanofi, and more.

Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.

Non-clinical toxicology study of investigational drug for psoriasis reveals worrying results.

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

We speak to the 2025 winner of Novo Nordisk and Pioneer Group’s Golden Ticket program.

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.